Related Experiment Video
Updated: Jun 19, 2025
Cholesterol Efflux Assay
Published on: March 6, 2012
Communication: High-Density Lipoprotein-Specific Phospholipid Efflux in Familial Hypercholesterolemia
Masaki Sato1,2, Masato Hamasaki1,2, Edward B Neufeld3
1Division of Community and Family Medicine, Jichi Medical University, Shimotsuke-City, Tochigi, Japan.
Insights
Familial hypercholesterolemia (FH) patients show impaired high-density lipoprotein (HDL) function, indicated by reduced HDL-specific phospholipid efflux. This dysfunction may contribute to cardiovascular disease (CVD) risk in FH, despite normal HDL-cholesterol levels.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder characterized by high low-density lipoprotein cholesterol (LDL-C) and increased cardiovascular disease (CVD) risk.
- While LDL-C's role in FH is established, the contribution of high-density lipoproteins (HDL) to CVD in FH remains unclear.
Purpose of the Study:
- To investigate the role of HDL functionality in cardiovascular disease (CVD) risk among patients with Familial hypercholesterolemia (FH).
- To assess HDL-specific phospholipid efflux (HDL-SPE) as a potential biomarker for CVD risk in FH.
Main Methods:
- Development of an HDL-specific phospholipid efflux (HDL-SPE) assay to predict CVD risk.
- Comparison of HDL-SPE levels in FH patients (n=30) versus age- and sex-matched non-FH controls (n=60).
Main Results:
- FH patients exhibited significantly lower HDL-SPE levels (0.90±0.12) compared to controls (1.12±0.10; p<0.05).
- HDL-cholesterol levels were similar between FH patients and controls (57.9±18.7 mg/dl vs. 57.1±13.8 mg/dl).
- The observed differences in HDL-SPE remained significant after adjusting for potential confounders.
Conclusions:
- Findings suggest potential HDL dysfunction in patients with Familial hypercholesterolemia.
- Reduced HDL-SPE may represent an underlying mechanism contributing to cardiovascular disease risk in FH.
Objective:
Familial hypercholesterolemia (FH) is characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C) and cardiovascular disease (CVD). Although the role of LDL-C in FH has been studied, the contribution of high-density lipoproteins (HDL) to CVD in FH remains unknown. This study aimed at highlighting the role of HDL in FH.
Methods:
HDL-specific phospholipid efflux (HDL-SPE) assay was developed to predict CVD risk. HDL-SPE was examined in FH patients (n=30) and compared with age- and sex-matched non-FH controls (n=60).
Results:
FH patients had significantly lower HDL-SPE levels (0.90±0.12) than controls (1.12±0.10; p<0.05), despite similar HDL-cholesterol levels in both groups (FH: 57.9±18.7 mg/dl; controls: 57.1±13.8 mg/dl). These differences remained significant after adjusting for confounders.
Conclusions:
These findings suggest there may be dysfunctionality of HDL in FH.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:24Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:39Receptor-mediated Endocytosis
01:27Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...